Octreotide and enterocutaneous fistula closure in neonates and children

详细信息    查看全文

• 作者：Noela Carrera-Guermeur ; Rosa M. Martín-Crespo…
• 关键词：Enterocutaneous fistula ; Neonate ; Octreotide ; Somatostatin
• 刊名：European Journal of Pediatrics
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：175
• 期：3
• 页码：305-312
• 全文大小：891 KB
• 参考文献：1.Alivizatos V, Felekis D, Zorbalas A (2002) Evaluation of the effectiveness of octreotide in the conservative treatment of postoperative enterocutaneous fistulas. Hepatogastroenterology 49(46):1010–1012PubMed
  2.Al-Hussaini A, Butzner D (2012) Therapeutic applications of octreotide in pediatric patients. Saudi J Gastroenterol 18(2):87–94PubMedCentral CrossRef PubMed
  3.Alvarez C, McFadden DW, Reber HA (2000) Complicated enterocutaneous fistulas: failure of octreotide to improve healing. World J Surg 24(5):533–537, discussion 538 CrossRef PubMed
  4.Arevalo RP, Bullabh P, Krauss AN, Auld PA, Spigland N (2003) Octreotide-induced hypoxemia and pulmonary hypertension in premature neonates. J Pediatr Surg 38(2):251–253CrossRef PubMed
  5.Bakhotmah MA (1996) Successful control of external biliary fistula by using SMS 201-995 in a child. HPB Surg 9(3):183–184PubMedCentral CrossRef PubMed
  6.Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179(4068):77–79CrossRef PubMed
  7.Budic I, Slavkovic A, Simic D, Djordjevic V, Novakovic D (2007) The role of octreotide in the treatment of pancreatic pseudocyst in pediatric patients: 10AP3-6. Eur J Anaesthesiol 24:133CrossRef
  8.Büyükyavuz I, Karnak I, Yiğit S, Tanyel FC (2004) Successful treatment of enterocutaneous fistula in a premature newborn by using octreotide. Turk J Pediatr 46(3):289–291PubMed
  9.Dorta G (1999) Role of octreotide and somatostatin in the treatment of intestinal fistulae. Digestion 60(Suppl 2):53–56CrossRef PubMed
  10.Draus JM Jr, Huss SA, Harty NJ, Cheadle WG, Larson GM (2006) Enterocutaneous fistula: are treatments improving? Surgery 140(4):570–576, discussion 576-578 CrossRef PubMed
  11.Dueno MI, Bai JC, Santangelo WC, Krejs GJ (1987) Effect of somatostatin analog on water and electrolyte transport and transit time in human small bowel. Dig Dis Sci 32(10):1092–1096CrossRef PubMed
  12.Fekete CN, Ricour C, Duhamel JF, Lecoultre C, Pellerin D (1978) Enterocutaneous fistulas of the small bowel in children (25 cases). J Pediatr Surg 13(1):1–4CrossRef PubMed
  13.Harris AG (1994) Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. Gut 35(3 Suppl):S1–S4PubMedCentral CrossRef PubMed
  14.Heikenen JB, Pohl JF, Werlin SL, Bucuvalas JC (2002) Octreotide in pediatric patients. J Pediatr Gastroenterol Nutr 35(5):600–609CrossRef PubMed
  15.Hesse U, Ysebaert D, de Hemptinne B (2001) Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: clinical data. Gut 49(Suppl 4):iv11–21PubMedCentral PubMed
  16.Hollington P, Mawdsley J, Lim W, Gabe SM, Forbes A, Windsor AJ (2004) An 11-year experience of enterocutaneous fistula. Br J Surg 91(12):1646–1651CrossRef PubMed
  17.Inamdar S, Slim MS, Bostwick H, Godine L (1990) Treatment of duodenocutaneous fistula with somatostatin analog in a child with dermatomyositis. J Pediatr Gastroenterol Nutr 10(3):402–404CrossRef PubMed
  18.Julia MV, Parri FJ, Albert A, Figueras J, Rovira J, Morales L (1989) Treatment of an enteric fistula with somatostatin in a premature. Clin Pediatr (Phila) 28(3):149–150CrossRef
  19.Karabulut R, Karakuş C, Hirfanoğlu I, Turan O, Türkyilmaz Z, Sönmez K, Onal EE, Atalay Y, Başaklar AC (2008) Treatment of postoperative enterocutaneous fistulas with octreotide in two neonates. Eur J Pediatr Surg 18(1):56–58CrossRef PubMed
  20.Laje P, Halaby L, Adzick NS, Stanley CA (2010) Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism. Pediatr Diabetes 11(2):142–147CrossRef PubMed
  21.Lam JC, Aters S, Tobias JD (2001) Initial experience with octreotide in the pediatric population. Am J Ther 8(6):409–415CrossRef PubMed
  22.Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ (1996) Octreotide. N Engl J Med 334(4):246–254CrossRef PubMed
  23.Leandros E, Antonakis PT, Albanopoulos K, Dervenis C, Konstadoulakis MM (2004) Somatostatin versus octreotide in the treatment of patients with gastrointestinal and pancreatic fistulas. Can J Gastroenterol 18(5):303–306PubMed
  24.Martinez JL, Luque-de-Leon E, Mier J, Blanco-Benavides R, Robledo F (2008) Systematic management of postoperative enterocutaneous fistulas: factors related to outcomes. World J Surg 32(3):436–443, discussion 444 CrossRef PubMed
  25.Mohseni-Bod H, Macrae D, Slavik Z (2004) Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe? Pediatr Crit Care Med 5(4):356–357CrossRef PubMed
  26.Mosdell KW, Visconti JA (1994) Emerging indications for octreotide therapy, Part 1. Am J Hosp Pharm 51(9):1184–1192PubMed
  27.Mosdell KW, Visconti JA (1994) Emerging indications for octreotide therapy, Part 2. Am J Hosp Pharm 51(10):1317–1330PubMed
  28.Mulligan C, Howell C, Hatley R, Martindale R, Clark J (1995) Conservative management of pediatric pancreatic pseudocyst using octreotide acetate. Am Surg 61(3):206–209PubMed
  29.Ohlbaum P, Galperine RI, Demarquez JL, Vergnes P, Martin C (1987) Use of a long-acting somatostatin analogue (SMS 201-995) in controlling a significant ileal output in a 5-year-old child. J Pediatr Gastroenterol Nutr 6(3):466–470CrossRef PubMed
  30.Paran H, Neufeld D, Kaplan O, Klausner J, Freund U (1995) Octreotide for treatment of postoperative alimentary tract fistulas. World J Surg 19(3):430–433, discussion 433 CrossRef PubMed
  31.Radetti G, Gentili L, Paganini C, Messner H (2000) Cholelithiasis in a newborn following treatment with the somatostatin analogue octreotide. Eur J Pediatr 159(7):550CrossRef PubMed
  32.Rahbour G, Siddiqui MR, Ullah MR, Gabe SM, Warusavitarne J, Vaizey CJ (2012) A meta-analysis of outcomes following use of somatostatin and its analogues for the management of enterocutaneous fistulas. Ann Surg 256(6):946–954CrossRef PubMed
  33.Reck-Burneo CA, Parekh A, Velcek FT (2008) Is octreotide a risk factor in necrotizing enterocolitis? J Pediatr Surg 43(6):1209–1210CrossRef PubMed
  34.Redfern JS, Fortuner WJ 2nd (1995) Octreotide-associated biliary tract dysfunction and gallstone formation: pathophysiology and management. Am J Gastroenterol 90(7):1042–1052PubMed
  35.Rushforth JA, Beck JM, McMahon M, Puntis JWL (1993) Resolution of pancreatic ascites with octreotide. Arch Dis Child 68:135–136PubMedCentral CrossRef PubMed
  36.Stavrou GA, Fischer R, Kaczmarek S, Kirschstein M, Oldhafer KJ (2008) Non-surgical management of a ruptured posttraumatic pancreatic pseudocyst in a child. Adv Med Sci 53(2):331–334CrossRef PubMed
  37.Stevens P, Foulkes RE, Hartford-Beynon JS, Delicata RJ (2011) Systematic review and meta-analysis of the role of somatostatin and its analogues in the treatment of enterocutaneous fistula. Eur J Gastroenterol Hepatol 23(10):912–922CrossRef PubMed
  38.Tauber MT, Harris AG, Rochiccioli P (1994) Clinical use of the long acting somatostatin analogue octreotide in pediatrics. Eur J Pediatr 153(5):304–310CrossRef PubMed
  39.Uba FA, Uba SC, Ojo EO (2012) Management of postoperative enterocutaneous fistulae in children: a decade experience in a single centre. Afr J Paediatr Surg 9(1):40–6CrossRef PubMed
  40.Wallace AM, Newman K (1991) Successful closure of intestinal fistulae in an infant using the somatostatin analogue SMS 201-995. J Pediatr Surg 26(9):1097–1100CrossRef PubMed
  41.Wensil AM, Balasubramanian SA, Bell TL (2011) Resolution of a posttraumatic pancreatic pseudocyst with octreotide acetate in a pediatric patient. Pharmacotherapy 31(9):924CrossRef PubMed
  
• 作者单位：Noela Carrera-Guermeur (1)
  Rosa M. Martín-Crespo (1)
  Hilda J. Ramírez (1)
  Ángel Pantoja (2)
  Rafael Luque-Mialdea (1)
  
  1. Department of Pediatric Surgery, Complejo Hospitalario de Toledo, Avenida de Barber, No 30, 45004, Toledo, Spain
  2. Division of Neonatology, Department of Pediatrics, Complejo Hospitalario de Toledo, Avenida de Barber, No 30, 45004, Toledo, Spain
  
• 刊物主题：Pediatrics;
• 出版者：Springer Berlin Heidelberg
• ISSN：1432-1076

文摘

Enterocutaneous fistula and its conservative management still pose a challenge for the surgeon. The use of octreotide and somatostatin in neonates and children as adjunctive therapy in the conservative management of this condition, leads to major controversy regarding its efficacy. Therefore, we conducted an extensive literature review of published articles regarding the use of somatostatin and its analogues in the treatment of enterocutaneous fistula in neonates and children. Our review is then presented together with a case vignette and discusses the different practical aspects of the treatment with these drugs.